Video
Dr. Palese discusses same-day discharge following transurethral BPH procedures
Author(s):
“Patients need to understand that even if you tell them that you may be doing this as an ambulatory procedure, they may actually have to stay afterwards, depending on what you find in the operating room or what happens in the postoperative period,” says Michael A. Palese, MD.
Video Player is loading.
In this video, Michael A. Palese, MD, discusses the key takeaways of the recent Urology study, “The utilization and safety of same-day discharge after transurethral benign prostatic hyperplasia surgery: a case-control, matched analysis of a national cohort,” for which he served as senior author. Palese is the chairman of the department of urology and a professor of urology at the Icahn School of Medicine, Mount Sinai, New York, New York.
Related Videos
Joy Maulik, CRNP, on the importance of genetic testing in prostate cancer
5 key trial insights from AUA 2025
Experts discuss expanding use of vibegron for OAB
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
BPH Treatment and Impact on Sexual Health
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Endourologist discusses shared decision-making and laser lithotripsy
Related Content
